nidНефрология и диализNephrology and Dialysis1680-44222618-9801Российское диализное обществоnid-3767Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСостояние иммунной системы при идиопатическом нефротическом синдроме (Лекция)Immune status in idiopathic nephrotic syndromeМоскалеваЕ. С.MoscalevaE. .noemail@neicon.ruРужицкаяЕ. А.RujitskayaE. .noemail@neicon.ruКатышеваО. В.KatyshevaO. .noemail@neicon.ruМалашинаО. А.MalashinaO. .noemail@neicon.ruМосковский НИИ педиатрии и детской хирургии МЗ РФRussian Federation20002806202523149154Copyright © Москалева Е.С., Ружицкая Е.А., Катышева О.В., Малашина О.А., 20252025Москалева Е.С., Ружицкая Е.А., Катышева О.В., Малашина О.А.Moscaleva E..., Rujitskaya E..., Katysheva O..., Malashina O...Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephro.ru/jour/article/view/3767

Нефротический синдром (НС) представляет собой симптомокомплекс, основным компонентом которого является экскреция с мочой значительного количества (более 3 г/сут) белка, в первую очередь альбуминов.

идиопатический нефротический синдромпатогенезиммунная системаинтерлейкиныReferencesДлин В.В. Патогенетическое значение персистирующей вирусной инфекции при гломерулонефрите у детей в обосновании противовирусной и иммуномодулирующей терапии. Дис.. докт. мед. наук, М., 1993.Длин В.В. Патогенетическое значение персистирующей вирусной инфекции при гломерулонефрите у детей в обосновании противовирусной и иммуномодулирующей терапии. Дис.. докт. мед. наук, М., 1993.Доломанова О.Е. Иммуноцитологические особенности и чувствительность к цитотоксическим препаратам у детей с первичным хроническим гломерулонефритом. Автореферат дис.. канд. мед. наук, М., 1991.Доломанова О.Е. Иммуноцитологические особенности и чувствительность к цитотоксическим препаратам у детей с первичным хроническим гломерулонефритом. Автореферат дис.. канд. мед. наук, М., 1991.Земсков А.М., Караулов А.В., Земсков В.М. Комбинированная иммунокоррекция. М., 1994; 260.Земсков А.М., Караулов А.В., Земсков В.М. Комбинированная иммунокоррекция. М., 1994; 260.Игнатова М.С., Москалева Е.С., Катышева О.В., Ружицкая Е.А. Динамика клинических и иммунологических показателей при лечении октагамом ребенка с нефротическим синдромом. Матер. I Конгресса «Современные методы диагностики и лечения нефроурологических заболеваний у детей», М., 1998; 97.Игнатова М.С., Москалева Е.С., Катышева О.В., Ружицкая Е.А. Динамика клинических и иммунологических показателей при лечении октагамом ребенка с нефротическим синдромом. Матер. I Конгресса «Современные методы диагностики и лечения нефроурологических заболеваний у детей», М., 1998; 97.Москалева Е.С. Клинико-патогенетическая характеристика нефротического синдрома у детей с атопическими реакциями. Дис.. канд. мед. наук, М., 1989.Москалева Е.С. Клинико-патогенетическая характеристика нефротического синдрома у детей с атопическими реакциями. Дис.. канд. мед. наук, М., 1989.Ракитинская И.А. Иммунология нефротического синдрома. В кн. Нефротический синдром., СПб., 1992; 33-55.Ракитинская И.А. Иммунология нефротического синдрома. В кн. Нефротический синдром., СПб., 1992; 33-55.Цыгин А.Н. Патогенетические основы первичного нефротического синдрома и лечения его тероидорезистентных вариантов у детей. Дис. канд., М., 1996.Цыгин А.Н. Патогенетические основы первичного нефротического синдрома и лечения его тероидорезистентных вариантов у детей. Дис. канд., М., 1996.Al-Azzawi Y.H., Altawil N.G., Alshamaa I.A. Lymphocyte transformation test in adult patients with minimal change nephrotic syndrome. Scand. J. Immunol., 1994; 40; 277-280.Al-Azzawi Y.H., Altawil N.G., Alshamaa I.A. Lymphocyte transformation test in adult patients with minimal change nephrotic syndrome. Scand. J. Immunol., 1994; 40; 277-280.Amore A., Coppo R. Short overview of the mechanisms of glomerular damage, repair and progression. Invited lecture, 34th Ann.Meeting of the ESPN, Helsinki, 2000./ Pediatr. Nephrol., 28.Amore A., Coppo R. Short overview of the mechanisms of glomerular damage, repair and progression. Invited lecture, 34th Ann.Meeting of the ESPN, Helsinki, 2000./ Pediatr. Nephrol., 28.Baud L., Fouqueray B., Bellocq A. Switching off renal inflammation by anti-inflammatory mediators: The facts, the promise and hope. Kidney Intern., 1998; 53: 1118-1126.Baud L., Fouqueray B., Bellocq A. Switching off renal inflammation by anti-inflammatory mediators: The facts, the promise and hope. Kidney Intern., 1998; 53: 1118-1126.Boulton-Jones J.M., Tulloch I., Dore B., McLay A. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin. Nephrol., 1983; 20: 72-77.Boulton-Jones J.M., Tulloch I., Dore B., McLay A. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin. Nephrol., 1983; 20: 72-77.Broyer M., Meyrier A., Niaudet P., Habib R. Minimal changes and focal segmental glomerular sclerosis. In:Сlinical Nephrology, Ed.A.M. Davison et al, Oxford, 1998; V.1; 1-3; 493-536.Broyer M., Meyrier A., Niaudet P., Habib R. Minimal changes and focal segmental glomerular sclerosis. In:Сlinical Nephrology, Ed.A.M. Davison et al, Oxford, 1998; V.1; 1-3; 493-536.Cambon-Thomsen A., Bouissou F., Abbal M. et al. HLA and B12 in idiopathic nephrotic syndrome of children. Differences between steroid sensitive and steroid resistant patients. Pathol. Biol., 1986; 34: 725-730.Cambon-Thomsen A., Bouissou F., Abbal M. et al. HLA and B12 in idiopathic nephrotic syndrome of children. Differences between steroid sensitive and steroid resistant patients. Pathol. Biol., 1986; 34: 725-730.Chen W.P., Lin C.Y. Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy. Nephron, 1994; 68: 10-19.Chen W.P., Lin C.Y. Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy. Nephron, 1994; 68: 10-19.Cho B.-S., Yoon S.-R., Jang J.-Y., Pyun K.-H., Lee C.-E. Up-regulation of interleukin-4 and CD23/Fc.RII in minimal change nephrotic syndrome. Pediatr. Nephrol., 1999; 13: 199-204.Cho B.-S., Yoon S.-R., Jang J.-Y., Pyun K.-H., Lee C.-E. Up-regulation of interleukin-4 and CD23/Fc.RII in minimal change nephrotic syndrome. Pediatr. Nephrol., 1999; 13: 199-204.Daniel V., Trautmann Y., Konrad M., Nayir A., Scharer K. T-lymphocyte populations, cytokins and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clinical Nephrology, 1997; 47 (5); 289-297.Daniel V., Trautmann Y., Konrad M., Nayir A., Scharer K. T-lymphocyte populations, cytokins and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clinical Nephrology, 1997; 47 (5); 289-297.Garin E.H., Laflam P., Chandler L. Anti-interleukin-8 antibody abolishes effects of lipoid nephrosis cytokine. Pediatr. Nephrol., 1998; 12: 381-385.Garin E.H., Laflam P., Chandler L. Anti-interleukin-8 antibody abolishes effects of lipoid nephrosis cytokine. Pediatr. Nephrol., 1998; 12: 381-385.Hewitt I.K., House A.K., Potter J.M., Kinnear B.F. Altered in vitro lymphocyte response in childhood nephrotic syndrome. Pediatr. Nephrol., 1992; 6; 464-466.Hewitt I.K., House A.K., Potter J.M., Kinnear B.F. Altered in vitro lymphocyte response in childhood nephrotic syndrome. Pediatr. Nephrol., 1992; 6; 464-466.Holdsworth S.R., Kitching A.R., Tipping P.G. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Intern., 1999; 55: 1198-1216.Holdsworth S.R., Kitching A.R., Tipping P.G. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Intern., 1999; 55: 1198-1216.Hulton S.A., Shan V., Byrne M.R., Morgan G., Barrat T.M., Dillon M.J. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr. Nephrol., 1994; 8: 135-139.Hulton S.A., Shan V., Byrne M.R., Morgan G., Barrat T.M., Dillon M.J. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr. Nephrol., 1994; 8: 135-139.Kawaguchi H., Yamaguchi Y., Nagata M. et al. The effects of human recombinant interleukin-2 on the permeability of glomerular basement membranes in rats. Japanese J. Nephrol., 1987; 29: 1-11.Kawaguchi H., Yamaguchi Y., Nagata M. et al. The effects of human recombinant interleukin-2 on the permeability of glomerular basement membranes in rats. Japanese J. Nephrol., 1987; 29: 1-11.Kimata H., Fujimoto M., Furusho K. Involvement of interleukin-13, but not IL-4, in spontaneous IgE production in nephrotic syndrome. Eur. J. Immunol., 1995; 25: 1497-1501.Kimata H., Fujimoto M., Furusho K. Involvement of interleukin-13, but not IL-4, in spontaneous IgE production in nephrotic syndrome. Eur. J. Immunol., 1995; 25: 1497-1501.Kobayashi Y., Yoshikawa N., Nakamura H. T-cell subpopulations in childhood nephrotic syndrome. Clin. Nephrol., 1994; 41: 253-258.Kobayashi Y., Yoshikawa N., Nakamura H. T-cell subpopulations in childhood nephrotic syndrome. Clin. Nephrol., 1994; 41: 253-258.Lagrue G., Xheneument S., Branellec A. et al. A vascular permeability factor elaborated from lymphocytes. Biomedicine, 1975; 23: 37-40.Lagrue G., Xheneument S., Branellec A. et al. A vascular permeability factor elaborated from lymphocytes. Biomedicine, 1975; 23: 37-40.Lin C.Y., Chen C.H., Lee P.P. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy. Pediatr. Nephrol., 1989; 3: 254-258.Lin C.Y., Chen C.H., Lee P.P. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy. Pediatr. Nephrol., 1989; 3: 254-258.Maruyama K., Tomizawa S. Vascular permeability factor. Abstr. XXYI Meet. Japan. SPN, 1991, S-II-4.Maruyama K., Tomizawa S. Vascular permeability factor. Abstr. XXYI Meet. Japan. SPN, 1991, S-II-4.Matsumoto K., Ohi H., Kanmatsuse K. Interleukin 10 and interleukin 13 synergise to inhibit vascular permeability factor by periferal blood mononuclear cells from patients with lipoid nephrosis. Nephron, 1997; 77: 212-218.Matsumoto K., Ohi H., Kanmatsuse K. Interleukin 10 and interleukin 13 synergise to inhibit vascular permeability factor by periferal blood mononuclear cells from patients with lipoid nephrosis. Nephron, 1997; 77: 212-218.Matsumoto K., Ohi H., Kanmatsuse K. Interleukin 12 upregulates the release of vascular permeability factor by periferal blood mononuclear cells from patients with lipoid nephrosis. Nephron, 1998; 78: 403-409.Matsumoto K., Ohi H., Kanmatsuse K. Interleukin 12 upregulates the release of vascular permeability factor by periferal blood mononuclear cells from patients with lipoid nephrosis. Nephron, 1998; 78: 403-409.Matsumoto K., Osakabe K., Katayama H., Hatano M. In vitro Lymphocyte dysfunction in lipoid nephrosis mediated by suppressor cells. Nephron, 1982; 32: 270-272.Matsumoto K., Osakabe K., Katayama H., Hatano M. In vitro Lymphocyte dysfunction in lipoid nephrosis mediated by suppressor cells. Nephron, 1982; 32: 270-272.Moorthy A.V., Zimmerman S.W., Burkholder P.M. Ingibitions of lymphocyte blastogenesis by plasma of patients with minimal change nephrotic syndrome. Lancet, 1976; 1160-1162.Moorthy A.V., Zimmerman S.W., Burkholder P.M. Ingibitions of lymphocyte blastogenesis by plasma of patients with minimal change nephrotic syndrome. Lancet, 1976; 1160-1162.Murer L. Focal segmental glomerular sclerosis of native and grafted kidney. Invited lecture, 34th Ann. Meeting of the ESPN, Helsinki, 2000./ Pediatr. Nephrol., 29.Murer L. Focal segmental glomerular sclerosis of native and grafted kidney. Invited lecture, 34th Ann. Meeting of the ESPN, Helsinki, 2000./ Pediatr. Nephrol., 29.Neuhaus T.J., Wadhwa M., Callard R., Barrat T.M. Increased IL-2, IL-4 and interferon-gamma in steroid-sensitive nephrotic syndrome. Clin. Exp. Immunol., 1995; 100: 475-479.Neuhaus T.J., Wadhwa M., Callard R., Barrat T.M. Increased IL-2, IL-4 and interferon-gamma in steroid-sensitive nephrotic syndrome. Clin. Exp. Immunol., 1995; 100: 475-479.Pirotski E., Pintos-Morell G., Burtin G. et al. Renal anaphylaxis. I. Antigen-initiated responses from isolated perfused rat kidney. Kidney Int., 1987; 32: 233-237.Pirotski E., Pintos-Morell G., Burtin G. et al. Renal anaphylaxis. I. Antigen-initiated responses from isolated perfused rat kidney. Kidney Int., 1987; 32: 233-237.Reeves W.G., Cameron J.S., Johansson I.G. et al. Seasonal nephrotic syndrome. Description and immunological findings. Clin. Allergy, 1975; 5: 121-137.Reeves W.G., Cameron J.S., Johansson I.G. et al. Seasonal nephrotic syndrome. Description and immunological findings. Clin. Allergy, 1975; 5: 121-137.Schnaper H.W. The immune system in minimal change nephrotic syndrome. Pediatric Nephrol., 1989; 3: 101-110.Schnaper H.W. The immune system in minimal change nephrotic syndrome. Pediatric Nephrol., 1989; 3: 101-110.Shalhoub R.J. Pathogenesis of lipoid nephrosis a disorder of T-cell function. Lancet, 1974, ii: 556-570.Shalhoub R.J. Pathogenesis of lipoid nephrosis a disorder of T-cell function. Lancet, 1974, ii: 556-570.Stachowski J., Michalkiewicz J., Krynicki T. et al. Does disregulation of lymphokine production (IL-2, IL-4, IL-6, IFN-gamma) contribute to the suppressor-inducer CD45 RA+ CD4+) and suppressor effector (CD45 RA+ CD8+) T cell activity in primary nephrotic syndrome. Abstr. 27th Ann. Meet. ESPN, 1993, F8.Stachowski J., Michalkiewicz J., Krynicki T. et al. Does disregulation of lymphokine production (IL-2, IL-4, IL-6, IFN-gamma) contribute to the suppressor-inducer CD45 RA+ CD4+) and suppressor effector (CD45 RA+ CD8+) T cell activity in primary nephrotic syndrome. Abstr. 27th Ann. Meet. ESPN, 1993, F8.Stefanovic V., Golubovic E., Mitic-Zlatkovic M., Vlanovic P., Jovanovic O., Bogdanovic R. Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome. Pediatr. Nephrol., 1998; 12: 463-466.Stefanovic V., Golubovic E., Mitic-Zlatkovic M., Vlanovic P., Jovanovic O., Bogdanovic R. Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome. Pediatr. Nephrol., 1998; 12: 463-466.Tenbrock K., Muller-Berghaus J., Fuchshuber A. et al. Levamisole treatment in steroid sensitive and steroid resistant nephrotic syndrome. Pediatr. Nephrol., 1998; 12: 459-462.Tenbrock K., Muller-Berghaus J., Fuchshuber A. et al. Levamisole treatment in steroid sensitive and steroid resistant nephrotic syndrome. Pediatr. Nephrol., 1998; 12: 459-462.Yap H.K., Cheung W., Murugasu B., Jordan S.C. Downregulation of monokine genes in children with relapses of steroid-responsive nephrotic syndrome. Abstr.11th Congress of IPNA, London, 1998; 47.03 (0).Yap H.K., Cheung W., Murugasu B., Jordan S.C. Downregulation of monokine genes in children with relapses of steroid-responsive nephrotic syndrome. Abstr.11th Congress of IPNA, London, 1998; 47.03 (0).Yokoyama H.M. et al. Immunodinamics of minimal change nephrotic syndrome in adults.T and B lymphocyte subsets and serum immunoglobulin levels. Clin. Exp. Immunol., 1985; 61: 601-607.Yokoyama H.M. et al. Immunodinamics of minimal change nephrotic syndrome in adults.T and B lymphocyte subsets and serum immunoglobulin levels. Clin. Exp. Immunol., 1985; 61: 601-607.Zoch-Zwierz W., Wiercinski K., Zwierz K., Wasilewska A. Serum IgE, interleukine-2 and 4 and their soluble receptors in children with nephrotic syndrome. Abstr.11th Congress of IPNA, London, 1998; 17; 103.Zoch-Zwierz W., Wiercinski K., Zwierz K., Wasilewska A. Serum IgE, interleukine-2 and 4 and their soluble receptors in children with nephrotic syndrome. Abstr.11th Congress of IPNA, London, 1998; 17; 103.

The authors declare that there are no conflicts of interest present.